These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 27855513)

  • 1. Recent developments in circulating biomarkers in Parkinson's disease: the potential use of miRNAs in a clinical setting.
    Teixeira Dos Santos MC; Bell R; da Costa AN
    Bioanalysis; 2016 Dec; 8(23):2497-2518. PubMed ID: 27855513
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A panel of four decreased serum microRNAs as a novel biomarker for early Parkinson's disease.
    Dong H; Wang C; Lu S; Yu C; Huang L; Feng W; Xu H; Chen X; Zen K; Yan Q; Liu W; Zhang C; Zhang CY
    Biomarkers; 2016; 21(2):129-37. PubMed ID: 26631297
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Roles of Non-Coding RNAs as Novel Diagnostic Biomarkers in Parkinson's Disease.
    Manna I; Quattrone A; De Benedittis S; Iaccino E; Quattrone A
    J Parkinsons Dis; 2021; 11(4):1475-1489. PubMed ID: 34334422
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma-based circulating MicroRNA biomarkers for Parkinson's disease.
    Khoo SK; Petillo D; Kang UJ; Resau JH; Berryhill B; Linder J; Forsgren L; Neuman LA; Tan AC
    J Parkinsons Dis; 2012; 2(4):321-31. PubMed ID: 23938262
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tiny But Mighty: Promising Roles of MicroRNAs in the Diagnosis and Treatment of Parkinson's Disease.
    Wang Y; Yang Z; Le W
    Neurosci Bull; 2017 Oct; 33(5):543-551. PubMed ID: 28762215
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An overview of circulating cell-free microRNAs as putative biomarkers in Alzheimer's and Parkinson's Diseases.
    Batistela MS; Josviak ND; Sulzbach CD; de Souza RL
    Int J Neurosci; 2017 Jun; 127(6):547-558. PubMed ID: 27381850
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exosomal microRNAs in Parkinson's disease: insights into biomarker potential and disease pathology.
    Chandran D; Krishnan S; Urulangodi M; Gopala S
    Neurol Sci; 2024 Aug; 45(8):3625-3639. PubMed ID: 38532190
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miRNAs and target genes in the blood as biomarkers for the early diagnosis of Parkinson's disease.
    Liu X; Chen J; Guan T; Yao H; Zhang W; Guan Z; Wang Y
    BMC Syst Biol; 2019 Jan; 13(1):10. PubMed ID: 30665415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of blood serum micro-RNAs associated with idiopathic and LRRK2 Parkinson's disease.
    Botta-Orfila T; Morató X; Compta Y; Lozano JJ; Falgàs N; Valldeoriola F; Pont-Sunyer C; Vilas D; Mengual L; Fernández M; Molinuevo JL; Antonell A; Martí MJ; Fernández-Santiago R; Ezquerra M
    J Neurosci Res; 2014 Aug; 92(8):1071-7. PubMed ID: 24648008
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevated plasma miR-133b and miR-221-3p as biomarkers for early Parkinson's disease.
    Chen Q; Deng N; Lu K; Liao Q; Long X; Gou D; Bi F; Zhou J
    Sci Rep; 2021 Jul; 11(1):15268. PubMed ID: 34315950
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of a panel of five serum miRNAs as a biomarker for Parkinson's disease.
    Ding H; Huang Z; Chen M; Wang C; Chen X; Chen J; Zhang J
    Parkinsonism Relat Disord; 2016 Jan; 22():68-73. PubMed ID: 26631952
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potential utility of autoantibodies as blood-based biomarkers for early detection and diagnosis of Parkinson's disease.
    DeMarshall CA; Han M; Nagele EP; Sarkar A; Acharya NK; Godsey G; Goldwaser EL; Kosciuk M; Thayasivam U; Belinka B; Nagele RG;
    Immunol Lett; 2015 Nov; 168(1):80-8. PubMed ID: 26386375
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of aberrant circulating miRNAs in Parkinson's disease plasma samples.
    Chen L; Yang J; Lü J; Cao S; Zhao Q; Yu Z
    Brain Behav; 2018 Apr; 8(4):e00941. PubMed ID: 29670823
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum miR-221 serves as a biomarker for Parkinson's disease.
    Ma W; Li Y; Wang C; Xu F; Wang M; Liu Y
    Cell Biochem Funct; 2016 Oct; 34(7):511-515. PubMed ID: 27748571
    [TBL] [Abstract][Full Text] [Related]  

  • 15. microRNAs in Parkinson's Disease: From Pathogenesis to Novel Diagnostic and Therapeutic Approaches.
    Leggio L; Vivarelli S; L'Episcopo F; Tirolo C; Caniglia S; Testa N; Marchetti B; Iraci N
    Int J Mol Sci; 2017 Dec; 18(12):. PubMed ID: 29236052
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miRNAs as Circulating Biomarkers for Alzheimer's Disease and Parkinson's Disease.
    Mushtaq G; Greig NH; Anwar F; Zamzami MA; Choudhry H; Shaik MM; Tamargo IA; Kamal MA
    Med Chem; 2016; 12(3):217-25. PubMed ID: 26527155
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum microRNA expression levels in Turkish patients with Parkinson's disease.
    Ozdilek B; Demircan B
    Int J Neurosci; 2021 Dec; 131(12):1181-1189. PubMed ID: 32546033
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Can Biomarkers Help the Early Diagnosis of Parkinson's Disease?
    Le W; Dong J; Li S; Korczyn AD
    Neurosci Bull; 2017 Oct; 33(5):535-542. PubMed ID: 28866850
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Altered Expression Levels of MicroRNA-132 and Nurr1 in Peripheral Blood of Parkinson's Disease: Potential Disease Biomarkers.
    Yang Z; Li T; Li S; Wei M; Qi H; Shen B; Chang RC; Le W; Piao F
    ACS Chem Neurosci; 2019 May; 10(5):2243-2249. PubMed ID: 30817108
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Candidate biomarkers for Parkinson's disease.
    Khodadadian A; Hemmati-Dinarvand M; Kalantary-Charvadeh A; Ghobadi A; Mazaheri M
    Biomed Pharmacother; 2018 Aug; 104():699-704. PubMed ID: 29803930
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.